Skip to main content
PAS 2024 Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Conference Ticketed Event
Pre-Conference Ticketed Event
APA Award Winner
APA Award Winner
APS Award Winner
APS Award Winner
ASPN Award Winner
ASPN Award Winner
SPR Award Winner
SPR Award Winner
On Demand Presentation
On Demand Presentation
Poster Icons
SPR Award Winner
SPR Award Winner
Back
Evaluation ViewAttendees 20
Oral Abstract

PIDS Top Abstracts
Session Type: Oral Abstract

PIDS Top Abstracts

Monday, May 6, 2024
8:00 AM – 9:30 AM ET
Location: Metro Toronto Convention Centre: 201 F
CE: Live CME: 1.5

Disclosure(s):
Kari A. Simonsen, MD, MBA: Astra-Zeneca (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Melinta Therapeutics (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)
Deb Palazzi, MD, MEd: Agency for Healthcare Research and Quality (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Elsevier (Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties); JAMA Pediatrics (Ongoing) (Products/Services: Board Member or Executive Role); Pediatric infectious Diseases Society (Ongoing) (Products/Services: Board Member or Executive Role); PEW Charitable Trust (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)
Gail J. Demmler Harrison, MD: Elsevier (Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties); Medscape (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Merck (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Microgen (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Moderna (Ongoing) (Products/Services: Advisory Committee, Consultant); Wolters Kluwer (Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties)

Presentations:

  • 8:00 AM – 8:15 AM ET
    Treatment Failure and Adverse Events After Short vs Long Treatment of Pediatric Acute Sinusitis

    Presenting Author: Timothy Savage, MD, MPH, MSc (he/him/his) – Brigham and Women's Hospital / Boston Children's Hospital

  • 8:15 AM – 8:30 AM ET
    Duration of Therapy for Escherichia coli Bacteremia Without Meningitis in the NICU: is shorter better?

    Presenting Author: Ashley Stark, MD, MS – Duke University School of Medicine

  • 8:30 AM – 8:45 AM ET
    Use of COVID-19 Antiviral Treatment in Children: Few, Far Between and Inconsistent

    Presenting Author: Lorne Walker, MD, PhD (he/him/his) – OHSU

  • 8:45 AM – 9:00 AM ET
    Comorbidities and the Risk of Critical COVID-19 in Children and Adolescents: A Systematic Review and Meta-Analysis

    Presenting Author: Camila Aparicio (she/her/hers) – Yale School of Medicine

  • 9:00 AM – 9:15 AM ET
    Prenatal Zika virus exposure is associated with immature social-emotional development and brain volume changes in a translational macaque model

    Presenting Author: Emma L. Mohr, MD, PhD (she/her/hers) – UNIVERSITY OF WISCONSIN-MADISON

  • 9:15 AM – 9:30 AM ET
    An Accelerated Scoring Model for Early Prediction of Complicated Osteomyelitis in Children

    Presenting Author: Tahmina A. Jahan, MD (she/her/hers) – Seattle Children's Hospital